Disease_category,Disease,Protein,Protein_definition,method,nsnp,OR [95% CI],Pvalue,QTL_type
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,21,2.23 [1.47-3.37],0.000145347275612523,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PGF,Placenta growth factor,Inverse variance weighted,2,13.6 [3.31-55.95],0.000297837712110519,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HSPB6,Heat shock protein beta-6,Wald ratio,1,16.88 [3.28-86.9],0.000725388356839836,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TGFA,Protransforming growth factor alpha,Inverse variance weighted,2,2.28 [1.33-3.9],0.0027123348380076,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD74,HLA class II histocompatibility antigen gamma chain,Wald ratio,1,9.24 [1.93-44.29],0.00540827645696624,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OCLN,Occludin,Inverse variance weighted,2,0.48 [0.28-0.81],0.00643534387444858,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,6,1.73 [1.15-2.62],0.00910132782948589,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS4,Galectin-4,Inverse variance weighted,4,0.59 [0.39-0.88],0.0101946955258768,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,11,0.74 [0.59-0.94],0.0118963853051985,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MZB1,Marginal zone B- and B1-cell-specific protein,Wald ratio,1,9.28 [1.6-53.82],0.0129887501676702,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,13,1.24 [1.04-1.46],0.0147420813688446,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,13,0.84 [0.72-0.98],0.0231472530814127,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,9,0.79 [0.64-0.97],0.0275813384726225,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,21,0.9 [0.82-0.99],0.0349602532484514,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,30,0.88 [0.78-0.99],0.0361558157161777,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PRSS8,Prostasin,Inverse variance weighted,5,1.59 [1.01-2.49],0.0432561879161467,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EFNA4,Ephrin-A4,Inverse variance weighted,3,0.46 [0.21-0.98],0.0454445326291042,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MMP12,Macrophage metalloelastase,Inverse variance weighted,18,0.89 [0.79-1],0.0477033648581014,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,7,0.68 [0.46-1],0.0517314512078486,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,16,0.83 [0.68-1.01],0.0623224542379171,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,10,1.16 [0.99-1.35],0.0653740412649217,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,1.4 [0.97-2.04],0.0737467827098717,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,25,1.12 [0.99-1.26],0.0832850801537966,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,19,0.93 [0.85-1.01],0.0884231627006336,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ANGPT2,Angiopoietin-2,Inverse variance weighted,4,0.75 [0.54-1.04],0.0889145671865034,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPP1,Osteopontin,Inverse variance weighted,8,0.69 [0.44-1.06],0.0892076447611751,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BTN2A1,Butyrophilin subfamily 2 member A1,Wald ratio,1,0.54 [0.26-1.1],0.090382803239081,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,10,0.85 [0.71-1.03],0.098448921920235,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,8,0.84 [0.69-1.03],0.101506472705684,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SHISA5,Protein shisa-5,Inverse variance weighted,5,2.16 [0.84-5.56],0.111068819666939,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,17,0.86 [0.72-1.04],0.112128556151739,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,22,0.9 [0.79-1.03],0.122202261136672,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1.17 [0.96-1.42],0.122825575705368,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,13,1.16 [0.96-1.39],0.123983493387027,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BTN3A2,Butyrophilin subfamily 3 member A2,Inverse variance weighted,4,0.81 [0.61-1.07],0.140012505844771,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD27,CD27 antigen,Inverse variance weighted,9,0.87 [0.72-1.05],0.146876166453914,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CNTN5,Contactin-5,Inverse variance weighted,28,1.09 [0.97-1.22],0.151898883649741,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ANGPTL4,Angiopoietin-related protein 4,Inverse variance weighted,7,0.87 [0.71-1.06],0.157011134974142,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NPPB,Natriuretic peptides B,Inverse variance weighted,3,0.78 [0.55-1.1],0.157314160293884,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FSTL1,Follistatin-related protein 1,Inverse variance weighted,3,0.75 [0.5-1.12],0.159978945644469,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD48,CD48 antigen,Inverse variance weighted,18,0.93 [0.84-1.03],0.160504694178506,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VSIG2,V-set and immunoglobulin domain-containing protein 2,Inverse variance weighted,5,1.27 [0.91-1.77],0.160576266688515,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CSTB,Cystatin-B,Inverse variance weighted,28,0.91 [0.81-1.04],0.161074728002929,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GUCA2A,Guanylin,Inverse variance weighted,9,0.81 [0.6-1.09],0.163154457097458,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,7,0.82 [0.62-1.09],0.163717237700649,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RSPO3,R-spondin-3,Inverse variance weighted,6,0.76 [0.52-1.12],0.164731969524428,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,JAM2,Junctional adhesion molecule B,Inverse variance weighted,2,2.02 [0.75-5.47],0.166651943622342,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PI3,Elafin,Inverse variance weighted,10,0.88 [0.72-1.06],0.174856413249911,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNASET2,Ribonuclease T2,Inverse variance weighted,14,0.88 [0.72-1.06],0.177761118819671,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD300C,CMRF35-like molecule 6,Inverse variance weighted,12,0.92 [0.81-1.04],0.182591608166345,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,0.75 [0.49-1.15],0.188394900278326,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC14A,C-type lectin domain family 14 member A,Wald ratio,1,0.6 [0.28-1.3],0.195917374584343,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,6,1.19 [0.91-1.56],0.201487712072005,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,11,1.29 [0.87-1.92],0.203693307918641,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PLXNB2,Plexin-B2,Inverse variance weighted,27,1.05 [0.97-1.14],0.204479438332883,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,5,0.78 [0.53-1.15],0.205973291658847,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,14,1.1 [0.95-1.26],0.208365903410355,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BSG,Basigin,Wald ratio,1,1.35 [0.85-2.14],0.209116694230592,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AGR2,Anterior gradient protein 2 homolog,Wald ratio,1,1.46 [0.81-2.63],0.210913200502675,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CST3,Cystatin-C,Inverse variance weighted,10,0.88 [0.73-1.07],0.213620043367412,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,7,1.16 [0.91-1.47],0.221733412631583,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,2,0.55 [0.2-1.46],0.228782493130064,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,14,1.12 [0.93-1.35],0.228871727561758,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MMP7,Matrilysin,Inverse variance weighted,13,0.9 [0.76-1.07],0.236165159297986,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PALM2,Paralemmin-2,Inverse variance weighted,8,0.85 [0.65-1.11],0.237480325162776,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,19,1.1 [0.94-1.3],0.23800396685062,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GDF15,Growth/differentiation factor 15,Inverse variance weighted,12,1.26 [0.86-1.86],0.239277991423503,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NECTIN4,Nectin-4,Inverse variance weighted,7,1.15 [0.91-1.44],0.241005418159425,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NRP1,Neuropilin-1,Inverse variance weighted,12,1.11 [0.93-1.32],0.258254058736843,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS3,Galectin-3,Inverse variance weighted,25,1.08 [0.95-1.22],0.265614563085345,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TFF1,Trefoil factor 1,Inverse variance weighted,8,0.88 [0.7-1.11],0.267602729005356,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,KLK11,Kallikrein-11,Inverse variance weighted,6,0.93 [0.81-1.06],0.27187341264318,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ELN,Elastin,Inverse variance weighted,2,0.63 [0.27-1.47],0.284596323945032,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,7,0.79 [0.51-1.22],0.288518227321446,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,6,0.87 [0.67-1.13],0.290269878755178,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,10,1.18 [0.87-1.6],0.292368252191266,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,25,1.07 [0.94-1.22],0.294037824739238,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,6,0.86 [0.64-1.14],0.295782233870556,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.57 [0.2-1.65],0.30233746171194,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,12,1.11 [0.9-1.37],0.307953093086396,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,4,1.28 [0.8-2.04],0.308973782328659,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PSAP,Prosaposin,Inverse variance weighted,5,0.86 [0.65-1.15],0.309148725304713,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,10,0.88 [0.69-1.13],0.318349455542883,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,INHBB,Inhibin beta B chain,Inverse variance weighted,10,1.08 [0.92-1.27],0.324459908988098,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ULBP2,UL16-binding protein 2,Inverse variance weighted,25,1.06 [0.95-1.18],0.331233454996159,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCN4,CCN family member 4,Inverse variance weighted,27,0.95 [0.84-1.06],0.335230804593561,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,5,0.84 [0.58-1.21],0.343204271194439,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,5,0.9 [0.73-1.12],0.354502273586138,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,6,0.87 [0.65-1.17],0.355107430906972,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.84 [0.59-1.21],0.356808359269202,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,0.7 [0.32-1.51],0.360480073715212,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,12,1.12 [0.88-1.43],0.362936934948659,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OMG,Oligodendrocyte-myelin glycoprotein,Wald ratio,1,1.46 [0.64-3.35],0.367315599943185,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,6,0.83 [0.55-1.25],0.369154717307889,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,46,0.97 [0.9-1.04],0.379441847233014,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,20,0.93 [0.78-1.1],0.382063582677205,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,4,0.89 [0.67-1.17],0.393158427079716,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,3,0.69 [0.3-1.61],0.394154468150295,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL15,C-C motif chemokine 15,Inverse variance weighted,22,1.04 [0.95-1.14],0.396119132727811,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,5,0.83 [0.53-1.31],0.426190605193552,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP4,Insulin-like growth factor-binding protein 4,Wald ratio,1,1.83 [0.41-8.29],0.430458472263362,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DPT,Dermatopontin,Inverse variance weighted,21,1.07 [0.9-1.26],0.435092491075255,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FAM3C,Protein FAM3C,Inverse variance weighted,2,1.63 [0.48-5.52],0.436286759582178,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL15RA,Interleukin-15 receptor subunit alpha,Inverse variance weighted,14,0.92 [0.74-1.14],0.437037144808962,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,KRT19,"Keratin, type I cytoskeletal 19",Wald ratio,1,0.84 [0.54-1.31],0.442925197164204,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,27,1.05 [0.93-1.19],0.443552392220673,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,Inverse variance weighted,4,1.3 [0.66-2.55],0.445562626789998,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,7,1.1 [0.86-1.41],0.44640975682793,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,14,1.12 [0.83-1.51],0.451200867046285,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LCN2,Neutrophil gelatinase-associated lipocalin,Wald ratio,1,2.06 [0.3-13.89],0.459984139003407,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,27,0.96 [0.85-1.07],0.460008430231713,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,3,1.62 [0.45-5.85],0.462169730327962,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,YAP1,Transcriptional coactivator YAP1,Wald ratio,1,0.69 [0.25-1.9],0.470041256541329,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RETN,Resistin,Inverse variance weighted,9,0.95 [0.83-1.09],0.473025401194788,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS9,Galectin-9,Inverse variance weighted,26,0.95 [0.83-1.09],0.476094757937816,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,29,1.03 [0.95-1.13],0.476227331897405,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CA12,Carbonic anhydrase 12,Inverse variance weighted,13,0.94 [0.8-1.11],0.476557823716882,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,10,1.06 [0.9-1.24],0.477030411487731,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SEPTIN8,Septin-8,Inverse variance weighted,2,1.18 [0.75-1.84],0.479916225699599,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,2,0.74 [0.32-1.7],0.480630038570679,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,10,1.07 [0.89-1.28],0.481281290306443,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TCN2,Transcobalamin-2,Inverse variance weighted,34,0.96 [0.85-1.08],0.485613461544939,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL15,Interleukin-15,Wald ratio,1,0.12 [0-50.49],0.487361009374446,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPON2,Spondin-2,Inverse variance weighted,4,1.12 [0.82-1.53],0.488912204873415,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,5,1.11 [0.82-1.5],0.489464212778291,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EFNA1,Ephrin-A1,Inverse variance weighted,11,0.94 [0.78-1.12],0.490915760600365,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,33,0.96 [0.85-1.08],0.491264680689573,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Wald ratio,1,0.56 [0.11-2.95],0.492451950205897,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,2,1.22 [0.69-2.15],0.499684549139001,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,8,1.07 [0.88-1.3],0.502035911764109,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL14,C-C motif chemokine 14,Inverse variance weighted,12,1.04 [0.92-1.17],0.508449686264032,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,2,0.82 [0.45-1.49],0.515702899455167,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,3,1.35 [0.55-3.31],0.516826044229386,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,15,0.94 [0.78-1.14],0.528316676523821,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,6,0.91 [0.66-1.24],0.532072402090227,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REN,Renin,Inverse variance weighted,4,1.07 [0.86-1.34],0.534944112152568,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SIGLEC1,Sialoadhesin,Inverse variance weighted,20,0.95 [0.82-1.11],0.536141988960364,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADM,Pro-adrenomedullin,Inverse variance weighted,2,0.72 [0.25-2.08],0.545388554907937,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Wald ratio,1,0.74 [0.27-1.99],0.547734953568379,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS1,Galectin-1,Inverse variance weighted,6,0.94 [0.79-1.14],0.54842356621346,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NECTIN2,Nectin-2,Inverse variance weighted,5,0.95 [0.79-1.13],0.549487459551131,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AREG,Amphiregulin,Inverse variance weighted,3,0.88 [0.58-1.34],0.552016831518261,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FOLR1,Folate receptor alpha,Inverse variance weighted,5,1.18 [0.68-2.05],0.559990014832498,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,1.18 [0.67-2.1],0.561775650774782,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,22,0.95 [0.82-1.12],0.561825861467168,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,4,0.91 [0.65-1.26],0.562377114918647,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,2,0.86 [0.5-1.46],0.569561015290081,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,0.67 [0.17-2.66],0.570643223435604,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,6,0.98 [0.9-1.06],0.573545282678026,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,22,1.04 [0.9-1.22],0.579648047665687,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,2,1.64 [0.26-10.27],0.598093834108426,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL3,C-C motif chemokine 3,Inverse variance weighted,9,0.95 [0.79-1.15],0.600012011792226,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,10,1.09 [0.8-1.48],0.603520895619593,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,7,0.95 [0.77-1.16],0.619221570863752,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DSC2,Desmocollin-2,Inverse variance weighted,9,1.06 [0.85-1.31],0.62154418485007,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,2,0.85 [0.44-1.65],0.631287900097471,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,WNT9A,Protein Wnt-9a,Inverse variance weighted,3,0.86 [0.46-1.61],0.632260452719113,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTSL,Cathepsin L1,Wald ratio,1,0.71 [0.18-2.85],0.634107284932848,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,20,1.03 [0.91-1.18],0.639678038505254,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,36,0.98 [0.89-1.07],0.641736323017323,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,23,1.03 [0.91-1.15],0.655721095411569,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,10,1.07 [0.79-1.46],0.662428381794945,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LMNB2,Lamin-B2,Wald ratio,1,1.4 [0.3-6.56],0.669597817238327,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD46,Membrane cofactor protein,Wald ratio,1,0.86 [0.42-1.76],0.678643316340086,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL7,C-C motif chemokine 7,Inverse variance weighted,3,0.82 [0.32-2.1],0.683092916942038,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,3,0.93 [0.66-1.32],0.685501368064706,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,14,1.04 [0.85-1.27],0.687343466557431,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LAYN,Layilin,Inverse variance weighted,20,0.96 [0.77-1.19],0.690253702678104,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,C7,Complement component C7,Inverse variance weighted,38,1.02 [0.93-1.11],0.691053945905413,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCN3,CCN family member 3,Inverse variance weighted,19,0.96 [0.77-1.19],0.695473209328988,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNASE6,Ribonuclease K6,Inverse variance weighted,15,1.03 [0.9-1.18],0.695604458587507,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,Inverse variance weighted,4,1.12 [0.64-1.96],0.70090411239246,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EPHB4,Ephrin type-B receptor 4,Wald ratio,1,1.08 [0.72-1.64],0.704660654773798,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,21,1.04 [0.86-1.24],0.704886052926584,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,0.9 [0.52-1.56],0.706903289501084,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,2,1.11 [0.64-1.92],0.707386594646616,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,25,1.02 [0.92-1.14],0.70759211110082,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCN5,CCN family member 5,Inverse variance weighted,8,0.91 [0.55-1.5],0.707951548589669,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,UMOD,Uromodulin,Inverse variance weighted,29,0.98 [0.9-1.08],0.715375669091473,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC3B,Tetranectin,Inverse variance weighted,7,1.05 [0.81-1.37],0.717228563048405,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTSO,Cathepsin O,Inverse variance weighted,6,1.08 [0.72-1.62],0.72401425892662,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTSZ,Cathepsin Z,Inverse variance weighted,3,0.95 [0.71-1.28],0.729633844838996,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PDCD1,Programmed cell death protein 1,Inverse variance weighted,9,1.07 [0.72-1.58],0.731887587076658,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EGFR,Epidermal growth factor receptor,Inverse variance weighted,7,0.92 [0.58-1.47],0.732847227509172,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,2,1.12 [0.59-2.13],0.735098342742534,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,2,0.82 [0.26-2.59],0.741360896971963,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD160,CD160 antigen,Inverse variance weighted,11,1.03 [0.88-1.2],0.745305393951983,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,2,1.1 [0.6-2],0.757768016676199,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,25,0.99 [0.9-1.08],0.757908526899248,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,28,1.01 [0.92-1.11],0.758867269360814,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LMOD1,Leiomodin-1,Inverse variance weighted,5,1.09 [0.63-1.86],0.764601259688226,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COLEC12,Collectin-12,Inverse variance weighted,11,0.95 [0.69-1.32],0.769265533245604,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,7,0.96 [0.72-1.27],0.769466577704548,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD59,CD59 glycoprotein,Inverse variance weighted,4,1.04 [0.8-1.35],0.771787205977553,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,24,1.04 [0.8-1.34],0.776259034351759,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,15,1.02 [0.87-1.21],0.784866390230158,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OGN,Mimecan,Inverse variance weighted,30,0.98 [0.86-1.12],0.794204035782261,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,8,1.02 [0.85-1.23],0.797702771401522,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GM2A,Ganglioside GM2 activator,Inverse variance weighted,24,1.01 [0.92-1.12],0.802255331229542,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLMP,CXADR-like membrane protein,Inverse variance weighted,12,1.02 [0.86-1.22],0.803511566357648,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADA2,Adenosine deaminase 2,Inverse variance weighted,8,0.97 [0.79-1.2],0.803670637869042,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RBP2,Retinol-binding protein 2,Wald ratio,1,1.13 [0.39-3.26],0.814606367113506,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL19,Interleukin-19,Inverse variance weighted,11,1.02 [0.85-1.24],0.815317145656973,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,2,0.94 [0.53-1.65],0.822049399836039,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SCARA5,Scavenger receptor class A member 5,Inverse variance weighted,10,1.03 [0.82-1.29],0.82418104128162,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,4,1.06 [0.62-1.82],0.825594659074377,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,2,0.92 [0.44-1.93],0.827868083479247,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FOLR2,Folate receptor beta,Inverse variance weighted,2,0.94 [0.57-1.58],0.828624916029155,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD276,CD276 antigen,Inverse variance weighted,20,0.99 [0.89-1.1],0.834478501159197,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,28,0.99 [0.86-1.13],0.841674047812518,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,5,0.96 [0.62-1.49],0.841926240424708,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EDN1,Endothelin-1,Inverse variance weighted,3,0.97 [0.73-1.29],0.844883444906339,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FSTL3,Follistatin-related protein 3,Inverse variance weighted,4,1.05 [0.64-1.71],0.847678944553271,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ITGA11,Integrin alpha-11,Inverse variance weighted,8,1.02 [0.81-1.29],0.849489804947752,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.14 [0.28-4.58],0.853753770592992,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,16,0.99 [0.87-1.12],0.855296400227072,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SLAMF8,SLAM family member 8,Inverse variance weighted,25,0.99 [0.92-1.07],0.856793766509926,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHGA,Chromogranin-A,Inverse variance weighted,3,1.03 [0.74-1.42],0.865313499875116,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,KLK4,Kallikrein-4,Inverse variance weighted,17,1.01 [0.88-1.17],0.868736744441413,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,17,1.01 [0.87-1.17],0.872761877538316,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ITGAV,Integrin alpha-V,Inverse variance weighted,5,1.07 [0.46-2.45],0.881045473304096,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,8,0.98 [0.75-1.29],0.883567872508934,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VWC2,Brorin,Inverse variance weighted,22,0.99 [0.84-1.16],0.884832760668826,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,5,0.96 [0.59-1.58],0.886596342808724,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD83,CD83 antigen,Inverse variance weighted,5,1.04 [0.61-1.77],0.888324109057689,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,4,1.02 [0.75-1.39],0.889016323761022,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,11,1.02 [0.8-1.3],0.893431890241921,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD302,CD302 antigen,Inverse variance weighted,9,1.01 [0.82-1.26],0.895791094184883,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FGF23,Fibroblast growth factor 23,Inverse variance weighted,2,0.96 [0.49-1.87],0.899986997954118,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,5,1.01 [0.83-1.23],0.911153493108415,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MDK,Midkine,Inverse variance weighted,4,0.95 [0.38-2.38],0.912960429649667,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,10,0.98 [0.71-1.35],0.916535842745713,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,19,1.01 [0.84-1.21],0.921673268360644,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,3,0.98 [0.61-1.57],0.922635416214688,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPON1,Spondin-1,Inverse variance weighted,21,1.01 [0.86-1.18],0.929624996620779,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,10,1.02 [0.7-1.47],0.931791426503308,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,12,0.99 [0.85-1.16],0.933566279251042,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD300E,CMRF35-like molecule 2,Inverse variance weighted,21,1.01 [0.85-1.2],0.933688000623869,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,10,1.01 [0.76-1.36],0.934168361078383,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,5,1.02 [0.6-1.74],0.940254483203042,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DLL1,Delta-like protein 1,Inverse variance weighted,7,1.01 [0.69-1.49],0.945955663081387,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,13,1 [0.87-1.14],0.946908587144021,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,3,1.03 [0.36-3],0.95023333237086,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL21,C-C motif chemokine 21,Inverse variance weighted,4,1.01 [0.62-1.65],0.954138305758157,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,44,1 [0.9-1.1],0.954652521817357,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SDC1,Syndecan-1,Inverse variance weighted,2,0.97 [0.27-3.46],0.957892526977529,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TFF2,Trefoil factor 2,Inverse variance weighted,5,0.99 [0.68-1.45],0.961473666457662,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,3,0.97 [0.23-4.05],0.969682142693495,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AMBP,Protein AMBP,Inverse variance weighted,3,0.99 [0.66-1.51],0.978714800297275,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TFF3,Trefoil factor 3,Inverse variance weighted,5,1 [0.7-1.42],0.985815286426094,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BCAN,Brevican core protein,Inverse variance weighted,3,1 [0.77-1.31],0.989207931867699,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AGRN,Agrin,Inverse variance weighted,17,1 [0.82-1.22],0.991496035824637,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,4,1 [0.71-1.42],0.993500235921321,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,24,1 [0.92-1.09],0.997980561088904,cis
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,Inverse variance weighted,23,1.38 [1.11-1.72],0.00397754863826978,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FABP1,"Fatty acid-binding protein, liver",Inverse variance weighted,2,0.21 [0.06-0.81],0.0237422126039942,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,Inverse variance weighted,3,2.67 [1.14-6.24],0.0237609923948335,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNF149,E3 ubiquitin-protein ligase RNF149,Inverse variance weighted,6,0.52 [0.28-0.97],0.0388670376057736,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD300C,CMRF35-like molecule 6,Inverse variance weighted,33,0.89 [0.8-1],0.0416616343302222,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPINK4,Serine protease inhibitor Kazal-type 4,Inverse variance weighted,14,1.41 [1.01-1.96],0.0419529166952457,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COLEC12,Collectin-12,Inverse variance weighted,3,2.52 [1.02-6.21],0.0441947240113139,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VSIG4,V-set and immunoglobulin domain-containing protein 4,Inverse variance weighted,12,1.5 [1-2.25],0.0498422059515108,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TIMP1,Metalloproteinase inhibitor 1,Inverse variance weighted,2,2.21 [0.99-4.9],0.0516009500710296,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CNTN5,Contactin-5,Inverse variance weighted,22,1.23 [1-1.53],0.0527008861946633,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MDK,Midkine,Inverse variance weighted,14,1.4 [0.99-1.96],0.0548770012871935,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FGF23,Fibroblast growth factor 23,Inverse variance weighted,15,1.34 [0.99-1.81],0.0562143589115843,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNASE1,Ribonuclease pancreatic,Inverse variance weighted,2,0.37 [0.13-1.06],0.0634578803343978,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SMOC1,SPARC-related modular calcium-binding protein 1,Inverse variance weighted,13,1.47 [0.97-2.21],0.0662229257022431,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,KLK11,Kallikrein-11,Inverse variance weighted,13,0.72 [0.51-1.02],0.0672030051794055,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHI3L1,Chitinase-3-like protein 1,Inverse variance weighted,5,0.55 [0.29-1.05],0.0678945927512749,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TIMP4,Metalloproteinase inhibitor 4,Inverse variance weighted,6,0.6 [0.35-1.04],0.0700058397428764,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ICAM1,Intercellular adhesion molecule 1,Inverse variance weighted,4,1.51 [0.96-2.38],0.0746014306430847,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FABP3,"Fatty acid-binding protein, heart",Inverse variance weighted,6,0.56 [0.28-1.1],0.0928914728571799,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DLL1,Delta-like protein 1,Inverse variance weighted,6,1.65 [0.92-2.97],0.0953128084231871,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD79B,B-cell antigen receptor complex-associated protein beta chain,Inverse variance weighted,21,0.83 [0.66-1.03],0.0966692646035249,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EPHA2,Ephrin type-A receptor 2,Inverse variance weighted,3,2.05 [0.85-4.91],0.107922463832757,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GAST,Gastrin,Inverse variance weighted,9,0.7 [0.45-1.1],0.11984948803402,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CRIP2,Cysteine-rich protein 2,Inverse variance weighted,6,2.06 [0.8-5.28],0.133869441045321,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL7,C-C motif chemokine 7,Inverse variance weighted,14,1.26 [0.93-1.71],0.136323311987944,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC7A,C-type lectin domain family 7 member A,Inverse variance weighted,6,1.47 [0.88-2.48],0.143620534784022,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NECTIN4,Nectin-4,Inverse variance weighted,4,1.88 [0.8-4.39],0.146974219470949,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPINT1,Kunitz-type protease inhibitor 1,Inverse variance weighted,12,1.25 [0.92-1.68],0.151814810333784,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL15RA,Interleukin-15 receptor subunit alpha,Wald ratio,1,0.35 [0.08-1.5],0.157319994997523,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL1RL1,Interleukin-1 receptor-like 1,Inverse variance weighted,27,1.21 [0.93-1.59],0.160887820550813,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CSF1,Macrophage colony-stimulating factor 1,Inverse variance weighted,6,1.56 [0.83-2.9],0.16380856308448,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ITGAV,Integrin alpha-V,Inverse variance weighted,10,0.73 [0.46-1.14],0.168161273693586,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CSTB,Cystatin-B,Inverse variance weighted,23,0.91 [0.8-1.04],0.175073638988003,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PALM2,Paralemmin-2,Inverse variance weighted,9,0.84 [0.65-1.08],0.176349091691413,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,Inverse variance weighted,2,2.05 [0.72-5.82],0.177314185149396,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LMOD1,Leiomodin-1,Inverse variance weighted,6,1.22 [0.91-1.63],0.183103381835756,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FGFR2,Fibroblast growth factor receptor 2,Inverse variance weighted,13,0.79 [0.55-1.12],0.184374709109413,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SDC1,Syndecan-1,Inverse variance weighted,12,1.25 [0.9-1.74],0.185903000807908,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD160,CD160 antigen,Inverse variance weighted,24,1.17 [0.92-1.49],0.198464184598185,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GPR37,Prosaposin receptor GPR37,Inverse variance weighted,32,1.12 [0.94-1.33],0.19997927596671,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PILRA,Paired immunoglobulin-like type 2 receptor alpha,Inverse variance weighted,27,0.9 [0.77-1.06],0.205616129469938,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,Wald ratio,1,2.39 [0.62-9.22],0.207550118020921,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,Inverse variance weighted,3,0.66 [0.34-1.28],0.217848514674607,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RBFOX3,RNA binding protein fox-1 homolog 3,Inverse variance weighted,2,0.5 [0.17-1.51],0.219965787618991,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,Inverse variance weighted,22,1.18 [0.9-1.55],0.223771716784408,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,Inverse variance weighted,20,0.81 [0.57-1.15],0.233752995875215,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL1R1,Interleukin-1 receptor type 1,Inverse variance weighted,14,1.21 [0.88-1.65],0.234529629483227,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NECTIN2,Nectin-2,Inverse variance weighted,3,1.87 [0.65-5.33],0.24272429390512,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ACE2,Angiotensin-converting enzyme 2,Inverse variance weighted,11,1.3 [0.84-2],0.245083566517614,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC14A,C-type lectin domain family 14 member A,Inverse variance weighted,3,1.38 [0.79-2.43],0.256367970952975,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FOLR2,Folate receptor beta,Inverse variance weighted,14,0.84 [0.62-1.14],0.259854355228464,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD302,CD302 antigen,Inverse variance weighted,11,0.84 [0.62-1.15],0.275440775610294,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GM2A,Ganglioside GM2 activator,Inverse variance weighted,2,1.81 [0.62-5.35],0.279611456685332,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GFRA1,GDNF family receptor alpha-1,Inverse variance weighted,10,1.12 [0.91-1.39],0.281352184235939,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTSO,Cathepsin O,Inverse variance weighted,19,1.1 [0.92-1.32],0.28147180278181,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ACVRL1,Serine/threonine-protein kinase receptor R3,Inverse variance weighted,6,0.81 [0.55-1.19],0.284352372619433,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPP1,Osteopontin,Inverse variance weighted,13,1.24 [0.84-1.83],0.285435513439718,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCN5,CCN family member 5,Inverse variance weighted,12,0.89 [0.71-1.1],0.286051429156397,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SIRPB1,Signal-regulatory protein beta-1,Inverse variance weighted,7,1.34 [0.78-2.29],0.29040738899937,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCN3,CCN family member 3,Inverse variance weighted,17,0.89 [0.71-1.11],0.291597781269746,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COL18A1,Collagen alpha-1(XVIII) chain,Inverse variance weighted,17,1.14 [0.9-1.44],0.295207258675354,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,Inverse variance weighted,2,1.85 [0.58-5.92],0.299787334394289,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ACTA2,"Actin, aortic smooth muscle",Wald ratio,1,0.57 [0.2-1.65],0.30233746171194,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HSPB6,Heat shock protein beta-6,Inverse variance weighted,4,0.62 [0.26-1.53],0.302628356026344,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,YAP1,Transcriptional coactivator YAP1,Inverse variance weighted,9,1.23 [0.83-1.83],0.30347673216481,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,Inverse variance weighted,4,1.52 [0.68-3.39],0.308451279896261,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTHRC1,Collagen triple helix repeat-containing protein 1,Inverse variance weighted,7,1.37 [0.75-2.5],0.308745891832187,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD46,Membrane cofactor protein,Inverse variance weighted,2,1.5 [0.68-3.33],0.315351065665381,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COL4A1,Collagen alpha-1(IV) chain,Inverse variance weighted,28,1.11 [0.91-1.35],0.32080108934451,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CA12,Carbonic anhydrase 12,Inverse variance weighted,9,0.73 [0.39-1.36],0.321605900139914,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCN4,CCN family member 4,Inverse variance weighted,29,0.93 [0.81-1.07],0.3239577521257,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL19,Interleukin-19,Inverse variance weighted,10,0.9 [0.72-1.12],0.333125317077114,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LTBP2,Latent-transforming growth factor beta-binding protein 2,Inverse variance weighted,12,0.74 [0.4-1.37],0.340974622057183,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TPP1,Tripeptidyl-peptidase 1,Inverse variance weighted,11,1.24 [0.8-1.93],0.343376677998964,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CKB,Creatine kinase B-type,Inverse variance weighted,11,1.22 [0.81-1.83],0.348533982916242,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HAVCR1,Hepatitis A virus cellular receptor 1,Inverse variance weighted,21,0.87 [0.64-1.17],0.348576363846999,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,Inverse variance weighted,35,1.06 [0.94-1.2],0.349826410292311,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NCS1,Neuronal calcium sensor 1,Inverse variance weighted,18,0.89 [0.69-1.14],0.352554921639131,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ATRAID,All-trans retinoic acid-induced differentiation factor,Inverse variance weighted,10,0.78 [0.47-1.31],0.353437837363424,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,Inverse variance weighted,4,0.84 [0.59-1.21],0.356808359269202,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHGA,Chromogranin-A,Inverse variance weighted,5,0.79 [0.47-1.33],0.373050717927801,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,C7,Complement component C7,Inverse variance weighted,26,1.06 [0.93-1.21],0.379692283885667,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NRP1,Neuropilin-1,Inverse variance weighted,14,0.86 [0.62-1.2],0.383278826157251,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MSR1,Macrophage scavenger receptor types I and II,Inverse variance weighted,18,1.17 [0.82-1.67],0.384429467982421,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNASET2,Ribonuclease T2,Inverse variance weighted,10,1.18 [0.81-1.74],0.389041549256693,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,WNT9A,Protein Wnt-9a,Wald ratio,1,2.19 [0.36-13.27],0.394161202235918,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OCLN,Occludin,Inverse variance weighted,2,0.51 [0.1-2.46],0.398675869473853,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL15,C-C motif chemokine 15,Inverse variance weighted,28,1.04 [0.95-1.13],0.400409699289586,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADGRG1,Adhesion G-protein coupled receptor G1,Inverse variance weighted,4,0.72 [0.33-1.57],0.406591763179684,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC6A,C-type lectin domain family 6 member A,Inverse variance weighted,13,1.15 [0.82-1.62],0.412179193934348,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHRDL1,Chordin-like protein 1,Inverse variance weighted,3,1.43 [0.6-3.4],0.412943337851952,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL3,C-C motif chemokine 3,Inverse variance weighted,15,0.93 [0.78-1.11],0.415239396593007,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LCN2,Neutrophil gelatinase-associated lipocalin,Inverse variance weighted,21,1.11 [0.87-1.42],0.418094094965372,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MZB1,Marginal zone B- and B1-cell-specific protein,Inverse variance weighted,18,1.12 [0.85-1.46],0.421754888876355,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FABP4,"Fatty acid-binding protein, adipocyte",Wald ratio,1,1.39 [0.61-3.12],0.432198200453338,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD14,Monocyte differentiation antigen CD14,Inverse variance weighted,6,1.21 [0.75-1.93],0.438159435430765,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC1A,C-type lectin domain family 1 member A,Inverse variance weighted,7,1.09 [0.88-1.35],0.43925521664219,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS4,Galectin-4,Inverse variance weighted,15,0.94 [0.8-1.1],0.440274633629976,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CRIM1,Cysteine-rich motor neuron 1 protein,Inverse variance weighted,7,0.84 [0.53-1.32],0.443815586661677,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD83,CD83 antigen,Inverse variance weighted,14,0.88 [0.63-1.22],0.446891620825658,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TFF1,Trefoil factor 1,Inverse variance weighted,14,0.93 [0.77-1.12],0.450639204932506,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DTX3,Probable E3 ubiquitin-protein ligase DTX3,Inverse variance weighted,13,1.11 [0.85-1.44],0.452356344867495,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD276,CD276 antigen,Inverse variance weighted,24,0.92 [0.74-1.15],0.461468586073026,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLMP,CXADR-like membrane protein,Inverse variance weighted,4,0.67 [0.23-1.95],0.464033863112049,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SCARB2,Lysosome membrane protein 2,Inverse variance weighted,10,1.26 [0.68-2.31],0.464546586770191,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL18BP,Interleukin-18-binding protein,Inverse variance weighted,10,0.85 [0.55-1.31],0.464558933135103,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CST3,Cystatin-C,Inverse variance weighted,3,1.43 [0.54-3.79],0.469575845340845,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BST2,Bone marrow stromal antigen 2,Inverse variance weighted,24,0.91 [0.69-1.19],0.470519493169286,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MMP7,Matrilysin,Wald ratio,1,0.81 [0.45-1.45],0.471521813893719,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LRRN1,Leucine-rich repeat neuronal protein 1,Inverse variance weighted,12,0.85 [0.53-1.34],0.48004580509773,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTSL,Cathepsin L1,Inverse variance weighted,29,0.93 [0.75-1.14],0.48015908621849,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,B2M,Beta-2-microglobulin,Inverse variance weighted,7,1.19 [0.72-1.98],0.491414240257551,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PLXNB2,Plexin-B2,Inverse variance weighted,12,0.81 [0.45-1.46],0.492823470209609,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PLAUR,Urokinase plasminogen activator surface receptor,Inverse variance weighted,8,1.15 [0.77-1.7],0.494613651125088,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,B4GALT1,"Beta-1,4-galactosyltransferase 1",Inverse variance weighted,12,0.91 [0.68-1.21],0.496622852508991,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VEGFA,Vascular endothelial growth factor A,Inverse variance weighted,15,0.9 [0.65-1.23],0.498098160923915,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PSAP,Prosaposin,Inverse variance weighted,13,0.93 [0.76-1.15],0.499774841448401,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,Inverse variance weighted,10,1.17 [0.74-1.83],0.501669122295742,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SMOC2,SPARC-related modular calcium-binding protein 2,Inverse variance weighted,11,1.17 [0.74-1.83],0.508502521389551,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NELL1,Protein kinase C-binding protein NELL1,Inverse variance weighted,33,0.95 [0.82-1.1],0.511870035222251,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,Inverse variance weighted,24,1.05 [0.91-1.21],0.517232079494088,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VCAM1,Vascular cell adhesion protein 1,Inverse variance weighted,9,1.19 [0.7-2],0.52449577412805,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ASGR1,Asialoglycoprotein receptor 1,Inverse variance weighted,7,0.83 [0.46-1.49],0.525609118491264,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LTBR,Tumor necrosis factor receptor superfamily member 3,Inverse variance weighted,9,1.14 [0.76-1.71],0.536661484576079,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ITGA11,Integrin alpha-11,Inverse variance weighted,7,0.89 [0.62-1.28],0.543737514280127,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,Inverse variance weighted,7,1.18 [0.69-2.01],0.551234047141845,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,KRT19,"Keratin, type I cytoskeletal 19",Inverse variance weighted,5,0.87 [0.54-1.39],0.563933195263655,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TGFA,Protransforming growth factor alpha,Inverse variance weighted,9,0.88 [0.55-1.38],0.567805782924755,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL10RB,Interleukin-10 receptor subunit beta,Inverse variance weighted,31,1.03 [0.93-1.14],0.573462689322164,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LMNB2,Lamin-B2,Inverse variance weighted,8,1.19 [0.64-2.22],0.574110817014369,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RNASE6,Ribonuclease K6,Inverse variance weighted,4,0.6 [0.1-3.56],0.575941908765234,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PDCD1,Programmed cell death protein 1,Inverse variance weighted,16,1.09 [0.8-1.5],0.578168819818694,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ULBP2,UL16-binding protein 2,Inverse variance weighted,9,0.91 [0.66-1.26],0.581294639384611,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,COL6A3,Collagen alpha-3(VI) chain,Inverse variance weighted,3,0.81 [0.37-1.75],0.583977820570358,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBPL1,Insulin-like growth factor-binding protein-like 1,Inverse variance weighted,4,0.77 [0.3-1.97],0.58841679382847,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LY6D,Lymphocyte antigen 6D,Inverse variance weighted,21,1.06 [0.87-1.28],0.589704090437646,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PRAP1,Proline-rich acidic protein 1,Inverse variance weighted,8,0.95 [0.78-1.15],0.591728063552711,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AGRN,Agrin,Inverse variance weighted,14,0.92 [0.67-1.26],0.594045745382397,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,UMOD,Uromodulin,Inverse variance weighted,34,0.95 [0.77-1.17],0.612493694214618,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AMBP,Protein AMBP,Inverse variance weighted,5,1.13 [0.7-1.8],0.621771553279107,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD59,CD59 glycoprotein,Inverse variance weighted,4,0.82 [0.37-1.81],0.624486262492522,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FOLR1,Folate receptor alpha,Inverse variance weighted,6,0.88 [0.53-1.47],0.624768792531366,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EBI3_IL27,Interleukin-27,Inverse variance weighted,26,0.96 [0.79-1.15],0.629103337139924,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RETN,Resistin,Inverse variance weighted,19,1.07 [0.82-1.39],0.631184507508396,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TAFA5,Chemokine-like protein TAFA-5,Inverse variance weighted,5,0.85 [0.43-1.67],0.633884623000484,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,Inverse variance weighted,6,1.11 [0.72-1.7],0.634580728058538,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS3,Galectin-3,Inverse variance weighted,15,1.07 [0.8-1.45],0.635463344345284,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TFF2,Trefoil factor 2,Inverse variance weighted,16,0.94 [0.72-1.22],0.644723850463079,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD4,T-cell surface glycoprotein CD4,Inverse variance weighted,6,1.17 [0.58-2.35],0.656754206728417,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LIFR,Leukemia inhibitory factor receptor,Inverse variance weighted,7,1.16 [0.59-2.31],0.662851595499599,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SEPTIN8,Septin-8,Inverse variance weighted,4,1.23 [0.48-3.14],0.664670496981065,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EPHB4,Ephrin type-B receptor 4,Inverse variance weighted,9,1.08 [0.75-1.56],0.676143941297076,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FGL1,Fibrinogen-like protein 1,Inverse variance weighted,7,1.16 [0.58-2.32],0.677177764903476,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL14,C-C motif chemokine 14,Inverse variance weighted,17,1.02 [0.91-1.15],0.680312791059666,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,Inverse variance weighted,5,1.15 [0.59-2.24],0.681460128048905,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL12RB1,Interleukin-12 receptor subunit beta-1,Inverse variance weighted,9,0.93 [0.64-1.34],0.68389293475103,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD48,CD48 antigen,Inverse variance weighted,14,0.93 [0.65-1.33],0.684763714053856,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,KLK4,Kallikrein-4,Inverse variance weighted,5,0.85 [0.38-1.89],0.687805740766977,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OSCAR,Osteoclast-associated immunoglobulin-like receptor,Inverse variance weighted,7,1.12 [0.65-1.93],0.690064666265344,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PLA2G15,Phospholipase A2 group XV,Inverse variance weighted,20,1.06 [0.79-1.43],0.691425090237585,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CXCL9,C-X-C motif chemokine 9,Inverse variance weighted,10,1.12 [0.65-1.94],0.692059692082361,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,VWC2,Brorin,Inverse variance weighted,12,1.09 [0.72-1.65],0.692845924817046,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SCARF2,Scavenger receptor class F member 2,Inverse variance weighted,6,0.88 [0.47-1.66],0.698947695218437,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RBP2,Retinol-binding protein 2,Inverse variance weighted,5,0.88 [0.45-1.71],0.707575291692317,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PGF,Placenta growth factor,Inverse variance weighted,5,0.91 [0.55-1.51],0.707610810703915,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PIGR,Polymeric immunoglobulin receptor,Inverse variance weighted,10,0.93 [0.64-1.36],0.71046629324769,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SHISA5,Protein shisa-5,Inverse variance weighted,12,1.09 [0.68-1.75],0.711442288867007,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL2RA,Interleukin-2 receptor subunit alpha,Inverse variance weighted,8,1.16 [0.53-2.54],0.713667477219428,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,Inverse variance weighted,8,0.92 [0.61-1.4],0.714370112070213,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP2,Insulin-like growth factor-binding protein 2,Inverse variance weighted,11,0.92 [0.6-1.42],0.721088655823744,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RELT,Tumor necrosis factor receptor superfamily member 19L,Inverse variance weighted,6,1.13 [0.57-2.24],0.725827841024052,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LAYN,Layilin,Inverse variance weighted,3,0.86 [0.35-2.07],0.730754595972676,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SORCS2,VPS10 domain-containing receptor SorCS2,Inverse variance weighted,6,1.09 [0.65-1.83],0.740073176277207,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,Inverse variance weighted,5,0.86 [0.35-2.14],0.742955666974612,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC5A,C-type lectin domain family 5 member A,Inverse variance weighted,10,1.07 [0.7-1.65],0.743370923638174,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,Inverse variance weighted,3,0.77 [0.15-3.84],0.747521968053488,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CDCP1,CUB domain-containing protein 1,Inverse variance weighted,9,0.94 [0.64-1.37],0.747863306107145,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NPC2,NPC intracellular cholesterol transporter 2,Inverse variance weighted,7,1.09 [0.63-1.89],0.749905516899288,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AGR2,Anterior gradient protein 2 homolog,Inverse variance weighted,2,1.13 [0.52-2.47],0.754756558633366,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CXADR,Coxsackievirus and adenovirus receptor,Inverse variance weighted,13,0.95 [0.68-1.32],0.757015270133898,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL15,Interleukin-15,Inverse variance weighted,35,0.97 [0.81-1.17],0.757405908264897,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REN,Renin,Inverse variance weighted,8,0.92 [0.54-1.58],0.757820953759988,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HPGDS,Hematopoietic prostaglandin D synthase,Inverse variance weighted,14,0.94 [0.66-1.36],0.760595670491963,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL4R,Interleukin-4 receptor subunit alpha,Inverse variance weighted,7,0.91 [0.51-1.64],0.760828586985015,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP4,Insulin-like growth factor-binding protein 4,Inverse variance weighted,3,1.13 [0.5-2.57],0.767945190631851,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DSC2,Desmocollin-2,Inverse variance weighted,16,1.03 [0.85-1.24],0.776983091155312,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADA2,Adenosine deaminase 2,Inverse variance weighted,10,1.06 [0.73-1.53],0.777174556927515,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,Inverse variance weighted,19,0.97 [0.8-1.18],0.779093375242961,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SLAMF8,SLAM family member 8,Inverse variance weighted,2,0.85 [0.28-2.64],0.782909860393654,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TFF3,Trefoil factor 3,Inverse variance weighted,10,1.05 [0.76-1.44],0.783316837934638,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TCN2,Transcobalamin-2,Inverse variance weighted,24,1.02 [0.86-1.22],0.784918790526296,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ANGPT2,Angiopoietin-2,Inverse variance weighted,7,1.08 [0.63-1.84],0.787042347991816,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REG3A,Regenerating islet-derived protein 3-alpha,Inverse variance weighted,20,0.97 [0.79-1.2],0.802360467438841,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD274,Programmed cell death 1 ligand 1,Inverse variance weighted,3,1.15 [0.39-3.39],0.804725826891167,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MMP12,Macrophage metalloelastase,Inverse variance weighted,2,1.14 [0.39-3.36],0.8125396253184,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CLEC3B,Tetranectin,Inverse variance weighted,2,0.87 [0.27-2.78],0.815021024329956,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CKAP4,Cytoskeleton-associated protein 4,Inverse variance weighted,6,0.95 [0.59-1.52],0.815392160125105,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,WFDC2,WAP four-disulfide core domain protein 2,Inverse variance weighted,4,1.06 [0.64-1.76],0.815663778244631,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,Inverse variance weighted,10,0.96 [0.7-1.33],0.819632124153961,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD300E,CMRF35-like molecule 2,Inverse variance weighted,35,1.02 [0.88-1.17],0.824823396069468,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,Inverse variance weighted,4,0.93 [0.48-1.79],0.825138989204913,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NBL1,Neuroblastoma suppressor of tumorigenicity 1,Inverse variance weighted,3,1.13 [0.38-3.41],0.826133195181306,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD80,T-lymphocyte activation antigen CD80,Inverse variance weighted,10,1.07 [0.57-2.01],0.826349184043452,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP7,Insulin-like growth factor-binding protein 7,Inverse variance weighted,4,1.07 [0.56-2.06],0.828222497559064,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPINK1,Serine protease inhibitor Kazal-type 1,Inverse variance weighted,5,1.08 [0.53-2.2],0.83004231235664,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD27,CD27 antigen,Inverse variance weighted,9,0.95 [0.57-1.57],0.831257934676972,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCDC80,Coiled-coil domain-containing protein 80,Inverse variance weighted,10,1.04 [0.71-1.54],0.831477318734298,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ANGPTL4,Angiopoietin-related protein 4,Wald ratio,1,1.17 [0.24-5.68],0.84260523181742,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DPT,Dermatopontin,Inverse variance weighted,4,0.93 [0.43-2.01],0.844664846707472,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DTNB,Dystrobrevin beta,Inverse variance weighted,2,1.1 [0.41-2.94],0.845987866096382,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SCARA5,Scavenger receptor class A member 5,Wald ratio,1,0.89 [0.25-3.12],0.854679479324954,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,Inverse variance weighted,25,1.02 [0.79-1.32],0.856296471421724,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LGALS9,Galectin-9,Inverse variance weighted,36,0.99 [0.87-1.12],0.857287865210145,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REG4,Regenerating islet-derived protein 4,Inverse variance weighted,13,0.97 [0.66-1.41],0.859517433627208,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,MERTK,Tyrosine-protein kinase Mer,Inverse variance weighted,28,0.98 [0.78-1.23],0.861925833819079,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LRP11,Low-density lipoprotein receptor-related protein 11,Inverse variance weighted,5,0.92 [0.36-2.39],0.869292896389473,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NT5C1A,Cytosolic 5'-nucleotidase 1A,Inverse variance weighted,4,0.97 [0.66-1.42],0.870781654726811,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NTproBNP,N-terminal prohormone of brain natriuretic peptide,Inverse variance weighted,11,1.04 [0.6-1.82],0.883584958147023,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,INHBB,Inhibin beta B chain,Inverse variance weighted,11,1.03 [0.7-1.52],0.883713226883946,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TGFBR2,TGF-beta receptor type-2,Inverse variance weighted,8,0.96 [0.57-1.61],0.886671585350694,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EFNA4,Ephrin-A4,Inverse variance weighted,2,0.95 [0.45-2.01],0.894858655718959,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EFNA1,Ephrin-A1,Inverse variance weighted,3,1.05 [0.5-2.21],0.896014784637578,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,HAVCR2,Hepatitis A virus cellular receptor 2,Inverse variance weighted,8,0.98 [0.76-1.27],0.89637461335109,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CCL21,C-C motif chemokine 21,Inverse variance weighted,15,1.03 [0.68-1.54],0.897409638206145,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PI3,Elafin,Inverse variance weighted,18,0.99 [0.82-1.19],0.90037370424997,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TNFSF13,Tumor necrosis factor ligand superfamily member 13,Inverse variance weighted,6,0.97 [0.56-1.67],0.903323738783163,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL1RN,Interleukin-1 receptor antagonist protein,Inverse variance weighted,4,1.05 [0.49-2.25],0.903423361187396,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GUCA2A,Guanylin,Inverse variance weighted,7,1.04 [0.58-1.86],0.905124383272187,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,Inverse variance weighted,3,0.94 [0.36-2.5],0.907464506119098,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PTGDS,Prostaglandin-H2 D-isomerase,Inverse variance weighted,9,0.97 [0.57-1.65],0.908213467734414,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,JAM2,Junctional adhesion molecule B,Inverse variance weighted,6,1.03 [0.6-1.79],0.910011224778781,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FSTL3,Follistatin-related protein 3,Inverse variance weighted,3,1.05 [0.43-2.59],0.91090779848253,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,PRSS8,Prostasin,Inverse variance weighted,14,1.02 [0.75-1.38],0.910951888882059,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ELN,Elastin,Inverse variance weighted,10,1.02 [0.66-1.58],0.914817593274413,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CTSZ,Cathepsin Z,Inverse variance weighted,16,1.01 [0.87-1.17],0.916507962125592,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EGFR,Epidermal growth factor receptor,Inverse variance weighted,8,0.96 [0.48-1.92],0.916816294868944,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ZBTB17,Zinc finger and BTB domain-containing protein 17,Wald ratio,1,1.05 [0.43-2.54],0.917610718968996,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IL6,Interleukin-6,Inverse variance weighted,6,0.99 [0.75-1.3],0.923026724444367,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OGN,Mimecan,Inverse variance weighted,37,1.01 [0.88-1.15],0.927852778197378,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,AREG,Amphiregulin,Inverse variance weighted,5,0.98 [0.55-1.74],0.932673886348833,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,IGFBP6,Insulin-like growth factor-binding protein 6,Inverse variance weighted,3,1.04 [0.41-2.63],0.93285937334718,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",Inverse variance weighted,24,1.01 [0.72-1.42],0.937180703821391,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,DCN,Decorin,Inverse variance weighted,2,1.19 [0.01-101.58],0.937389255716066,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,OMG,Oligodendrocyte-myelin glycoprotein,Inverse variance weighted,15,1.01 [0.73-1.41],0.942456296166696,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",Inverse variance weighted,2,0.98 [0.57-1.7],0.945015174304501,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,EDA2R,Tumor necrosis factor receptor superfamily member 27,Inverse variance weighted,12,0.99 [0.64-1.53],0.952627755185574,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,RSPO3,R-spondin-3,Inverse variance weighted,5,0.98 [0.57-1.7],0.955966998185399,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BSG,Basigin,Inverse variance weighted,6,0.99 [0.57-1.72],0.962222826068986,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NPDC1,Neural proliferation differentiation and control protein 1,Inverse variance weighted,7,1.02 [0.5-2.07],0.963602038164102,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,ADGRG2,Adhesion G-protein coupled receptor G2,Inverse variance weighted,8,1.01 [0.62-1.64],0.964428535178439,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPON1,Spondin-1,Inverse variance weighted,4,0.98 [0.44-2.19],0.967595444154735,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,GDF15,Growth/differentiation factor 15,Wald ratio,1,0.96 [0.15-6.34],0.96938420477734,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,TREM2,Triggering receptor expressed on myeloid cells 2,Inverse variance weighted,35,1 [0.88-1.14],0.975632391949262,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SPON2,Spondin-2,Inverse variance weighted,3,0.99 [0.28-3.51],0.983970196149062,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,BCAN,Brevican core protein,Inverse variance weighted,12,1 [0.59-1.72],0.985846580218893,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,REG1A,Lithostathine-1-alpha,Inverse variance weighted,13,1 [0.81-1.24],0.986561190465497,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FAM3C,Protein FAM3C,Inverse variance weighted,3,1 [0.5-1.97],0.989788627694626,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,CD74,HLA class II histocompatibility antigen gamma chain,Inverse variance weighted,7,1 [0.69-1.45],0.991237598290577,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,FSTL1,Follistatin-related protein 1,Inverse variance weighted,12,1 [0.68-1.47],0.991372468026348,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,SIGLEC1,Sialoadhesin,Inverse variance weighted,16,1 [0.71-1.41],0.996200920958769,trans
Chapter IX Diseases of the circulatory system,I9_CEREBDOTH,NEFL,Neurofilament light polypeptide,Inverse variance weighted,6,1 [0.38-2.61],0.997354888218413,trans
